MedTrace Logo

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

NCT00188539 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2026-03-06

No results posted yet for this study

Summary

The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.

Conditions

  • Cervix Neoplasms

Interventions

PROCEDURE

Pre-treatment tumour oxygen measurements (under anesthesia)

Sponsors & Collaborators

  • Canadian Cancer Trials Group

    collaborator NETWORK

  • Princess Margaret Hospital, Canada

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Michael F Milosevic · Princess Margaret Hospital, Canada

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-12-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00188539 on ClinicalTrials.gov